BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7632152)

  • 1. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment.
    Grossman RF; Tu SH; Duh QY; Siperstein AE; Novosolov F; Clark OH
    Arch Surg; 1995 Aug; 130(8):892-7; discussion 898-9. PubMed ID: 7632152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and biological features of familial nonmedullary thyroid carcinoma].
    Gao J; Yu Y; Li X; Zhao J; Zhao C; Zhao J; Liu Y; Li Y; Gao M
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial nonmedullary thyroid carcinoma: a meta-review of case series.
    Loh KC
    Thyroid; 1997 Feb; 7(1):107-13. PubMed ID: 9086578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
    Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
    J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
    Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
    Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Nonmedullary Thyroid Carcinoma: A Retrospective Analysis of 117 Families.
    Zhang YB; Wang XX; Zhang XW; Li ZJ; Liu J; Xu ZG; Tang PZ
    Chin Med J (Engl); 2018 Feb; 131(4):395-401. PubMed ID: 29451143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial papillary thyroid microcarcinoma: a new clinical entity.
    Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
    Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
    El Lakis M; Giannakou A; Nockel PJ; Wiseman D; Gara SK; Patel D; Sater ZA; Kushchayeva YY; Klubo-Gwiezdzinska J; Nilubol N; Merino MJ; Kebebew E
    Surgery; 2019 Jan; 165(1):50-57. PubMed ID: 30327187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of familial nonmedullary thyroid cancer in a large case series.
    Zivaljevic V; Paunovic I; Diklic A; Krgovic K; Kalezic N; Kazic M; Tatic S; Savic D; Stojanovic D; Perunovic R
    Acta Chir Belg; 2008; 108(3):328-32. PubMed ID: 18710108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognosis of familial follicular thyroid carcinoma.
    Ito Y; Fukushima M; Yabuta T; Inoue H; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Endocr J; 2008 Oct; 55(5):847-52. PubMed ID: 18506092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.
    Zhang W; Jiao D; Liu B; Sun S
    Med Sci Monit; 2016 Apr; 22():1274-9. PubMed ID: 27084873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 17. Operative strategy for thyroid cancer. Is total thyroidectomy worth the price?
    Schroder DM; Chambors A; France CJ
    Cancer; 1986 Nov; 58(10):2320-8. PubMed ID: 3756777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.
    Sippel RS; Caron NR; Clark OH
    World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological behavior and prognosis of familial papillary thyroid carcinoma.
    Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.